PONTE VEDRA, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Treace Medical Concepts Trading Up 5.6 % NASDAQ TMCI opened at $8.71 on Friday. Treace Medical Concepts, Inc. has a one year low of $3.92 and a one year high of $15.98. The firm has a market cap ...

At the beginning of last year, the government announced it was closing nine ServiceOntario locations and moving them into Staples Canada stores as part of a three-year pilot. The move meant paying ...

1 Day TMCI -4.19% DJIA 0.52% Russell 2K 1.13% Health Care/Life Sciences 0.39% ...

Treace, CEO, Founder and Board Member of Treace. “Driven by our active pipeline of differentiated technologies, we are excited to enter 2025 with multiple innovative product launches ...

Stifel Nicolaus analyst Rick Wise maintained a Hold rating on Treace Medical Concepts (TMCI – Research Report) yesterday. The company’s shares closed yesterday at $8.36. Discover outperforming ...

For this year’s first installment of The Strategist Beauty Brief, we asked the team to share their boring-but-beloved staples. The unsexy ointments, creams and kits they’ve been coming back ...

Medical device maker Surmodics (NASDAQ:SRDX) fell 6% after a report about the antitrust regulator's possible view of its planned sale to private equity firm GTCR. The Federal Trade Commission may ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

(RTTNews) - Treace Medical Concepts, Inc. (TMCI), Monday announced preliminary revenue for the fourth quarter and full year 2024, revealing an increase of nearly 10 percent and 12 percent ...